Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Visby Medical

Health Tech & Medtech · San Jose, United States · Founded 2012 Unicorn

Instrument-free, single-use, palm-sized PCR diagnostic devices.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value
Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

17 investors on Visby Medical's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Artiman Ventures
Series B+ 16 investors entered at this stage
Ping An Group
Plug and Play
J-Ventures
Pitango Venture Capital
Cedars-Sinai
Blue Water Life Science
+ND Capital
E Squared Capital Management
Valo Ventures
Hutchison Port Holdings Trust ADR
Catalio Capital Management
Lightrock
Healthcare of Ontario Pension Plan
Nissim Capital
John Doerr
Hutchison Group

Ownership

Who owns Visby Medical

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

18% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Visby Medical has talent and traffic

Workforce by country
6 countries with
team presence
🇺🇸 United States96.4%
🇮🇱 Israel1.6%
🇳🇱 Netherlands0.8%
🇨🇴 Colombia0.8%
🇦🇷 Argentina0.8%
Top 5 of 6 shown
Web traffic by country
9.2K monthly visits
across markets
🇺🇸 United States79.3%
🇮🇳 India12%
🇯🇵 Japan6.5%
🇬🇧 United Kingdom1.1%
🇵🇰 Pakistan1.1%
Top 5 markets shown

Talent graph

The shape of Visby Medical's talent

Dealroom maps Visby Medical's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

33 standout operatorsDealroom-flagged across the org
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Visby Medical's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$22M patent portfolio · 13 active families

Estimated portfolio value
$22M
2.2% of valuation · 26.5× larger than top peer Neko Health ($834k)
13 active patent families
Where Visby Medical innovates Molecular diagnosticsMolecular Diagnostic TestingMolecular biologyPolymeraseBiological organism

Where Visby Medical concentrates vs peers

Each axis is a top-10 topic across Visby Medical and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Visby Medical

An AI-synthesized read of the highest-engagement posts about Visby Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Visby Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles